BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9117091)

  • 1. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
    Wurch T; Palmier C; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
    Pauwels PJ; Wurch T; Palmier C; Colpaert FC
    Br J Pharmacol; 1998 Jan; 123(1):51-62. PubMed ID: 9484854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.
    Pauwels PJ; Palmier C; Wurch T; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):144-56. PubMed ID: 8717154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
    Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
    Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of cell growth by stimulation of cloned human 5-HT1D receptor sites in transfected C6-glial cells is highly sensitive to intrinsic activity at 5-HT1D receptors.
    Pauwels PJ; Wurch T; Palmier C; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):136-44. PubMed ID: 8857590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxytryptamine1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium.
    Bhattacharya A; Schenck KW; Xu YC; Nisenbaum L; Galbreath E; Cohen ML
    J Pharmacol Exp Ther; 2004 May; 309(2):825-32. PubMed ID: 14724223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
    Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
    Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
    Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
    Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
    Cohen ML; Schenck K
    J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential functional activity of 5-hydroxytryptamine receptor ligands and beta adrenergic receptor antagonists at 5-hydroxytryptamine1B receptor sites in Chinese hamster lung fibroblasts and opossum renal epithelial cells.
    Pauwels PJ; Palmier C
    J Pharmacol Exp Ther; 1994 Sep; 270(3):938-45. PubMed ID: 7932206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML; Schenck KW; Hemrick-Luecke SH
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
    Becker BN; Gettys TW; Middleton JP; Olsen CL; Albers FJ; Lee SL; Fanburg BL; Raymond JR
    Mol Pharmacol; 1992 Nov; 42(5):817-25. PubMed ID: 1331764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression.
    Verheggen R; Hundeshagen AG; Brown AM; Schindler M; Kaumann AJ
    Br J Pharmacol; 1998 Aug; 124(7):1345-54. PubMed ID: 9723944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation.
    Adham N; Zgombick JM; Bard J; Branchek TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):508-14. PubMed ID: 9808674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between partial and silent 5-HT1D beta receptor antagonists using rat C6-glial and Chinese hamster ovary cell lines permanently transfected with a cloned human 5-HT1D beta receptor gene.
    Pauwels PJ; Colpaert FC
    Biochem Pharmacol; 1995 Nov; 50(10):1651-8. PubMed ID: 7503768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.